A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction
Open Access
- 28 February 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (2) , 467-473
- https://doi.org/10.1016/s0735-1097(10)80117-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survivalJournal of the American College of Cardiology, 1988
- The thrombolysis in myocardial infarction (TIMI) phase II pilot study: Tissue plasminogen activator followed by percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1987
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation, 1987
- Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.Circulation, 1986
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Circulation Research, 1985
- Late effects of acute infarct dilation on heart size: a two dimensional echocardiographic studyThe American Journal of Cardiology, 1982
- Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function.Circulation Research, 1981